In commemoration of Wang Baoen
You Suning;

..............page:881-883

Long-term treatment of chronic hepatitis B

..............page:884-890

Relationship between hepatitis B virus polymerase gene mutation patterns of rtM204I/V and pre-core/basal core promoter mutations
Hou Jinlin;,Sun Jian;,Wang Jiefei;,Wang Zhanhui;,Yan Li;,Zhou Bin;

..............page:891-894

Dynamic changes of serum HBsAg levels at different grades of liver inflammation and stages of hepatic fibrosis in HBeAg-negative hepatitis B patients
Gao Zhiliang;,Ke Weimin;,Lai Jing;,Li Xiangyong;,Liu Ting;,Tan Lei;,Wu Zeqian;

..............page:895-899

Effective antiviral therapy with entecavir in chronic hepatitis B virus carriers
Mao Xiaoqin;,Yan Chengguo;,Yao Yunqing;

..............page:900-903

HLA class Ⅰ alleles and haplotypes in Chinese patients with primary biliary cirrhosis
huang chun yang ;, liao hui zuo ;, liu yan min ;, sun li mei ;, zuo hui ping ;, zhang hai ping ;, zhang xin ;, zhao dan tong ;

..............page:904-909

In vivo tracking of PKH26-labeled human umbilical cord mesenchymal stem cells after transplantation into rats with liver cirrhosis
Hou Yanning;,Li Jianli;,Liu Jianfang;,Wu Honghai;,Xue Gai;

..............page:910-914

Effect of miR-30a-5p on the proliferation, apoptosis, invasion and migration of SMCC-7721 human hepatocellular carcinoma cells
Dai Hang;,Kang Bing;,Zuo Deyu;,Zuo Guoqing;

..............page:915-920

Long-term survival trends for liver cancer in Qidong: 1972 to 2011
Chen Hao;,Chen Jianguo;,Yao Hairong;,Zhang Yonghui;,Zhu Jian;

..............page:921-925

A multi-center clinical study of a novel controlled attenuation parameter for assessment of fatty liver
chen guo feng ;, chen jian neng ;, zuo yu qiang ;, pan qin ;, shen feng ;, shi jun ping ;, xu lei ming ;, xu liang ;, zheng rui dan ;

..............page:926-931

Expression of intestinal defensin-5, soluble phospholipase A2 and lysozyme and the relation to bacterial translocation in rat models of acute liver failure
cheng na ;, cheng xiao yu ;, huang juan jun ;, lei wan ;, li xiao peng ;, liu bi xia ;, liu juan ;, zhang lun li ;

..............page:932-937

RUCAM scale-based diagnosis, clinical features and prognosis of 140 cases of drug-induced liver injury
Hao Kunyan;,He Changlun;,Li Xin;,Wang Maorong;,Wang Shouming;,Yu Yuecheng;

..............page:938-941

Association of intestinal epithelial tight junctions, E.coli, intestinal mucosa Toll-like receptor-4 and tumor necrosis factor-alpha in rabbit with non-alcoholic fatty liver disease
Gao Hongliang;,Wang Haikun;,Yao Ping;

..............page:942-947

Impact of JNK inhibitor XG-102 in a diet-induced rat model of non-alcoholic steatohepatitis
Chen Yilian;,Cheng Fangxiong;,Hu Yingbin;,Lei Deli;,Peng Na;

..............page:948-952

Unconditional logistic regression analysis of risk factors for nonalcoholic fatty liver disease in the Urumqi population
Cai Wen;,Lin Sulan;,Rebiguli· R-He-Man;,Song Jiangmei;,Xia Huiling;,Zhang Xiangyang;

..............page:953-954

Interferon treatment of chronic hepatitis C-induced ischemic bowel disease: two case reports and a literature review
Kang Yi;,Shang Jia;,Wei Junfeng;,Zeng Yanli;

..............page:955-957

Diagnosis and treatment of hyperosmolar non-ketotic hyperglycemic coma induced by glucocorticoid pulse therapy for acute rejection after liver transplantation
guo zhi yong ;, han ming ;, jiao xing yuan ;, ju wei qiang ;, zuo qiang ;, wang xiao ping ;, wu lin wei ;, yuan xiao peng ;, zhou jian ;

..............page:958

Biological function of IL-33 and hepatic fibrosis
An Haiyan;,Xu Jiabin;

..............page:959-960